[1. Adurthi S, Mukherjee G, Krishnamurthy H, Sudhir K, Bafna UD, Umadevi K, Jayshree RS. Functional tumour infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells // Int J Gynecol Cancer, 2012; 22:1130 – 1137]Search in Google Scholar
[2. Arany I, Grattendick KG, Tyring SK. Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5’-segment of the upstream regulatory region (URR) // Antiviral Res, 2002; 55:331-339]Search in Google Scholar
[3. Azar KK, Tani M, Yasuda H, Sakai A, Inoue M, Sasagawa T. Increased secretion patterns of interleukin-10 and tumour necrosis factor-alpha in cervical squamous intraepithelial lesions // Hum Pathol, 2004; 35:1376 – 1384]Search in Google Scholar
[4. Bae JY, Kim EK, Yang DH, Zhang X, Park YJ, Lee DY, Che CM, Kim J. Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression // Neoplasia, 2014; 16:928 – 938]Search in Google Scholar
[5. Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJ, Snijders PJ, Helmerhost TJ. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions // J Clin Pathol, 2005; 58: 1096 – 1100]Search in Google Scholar
[6. Behbakht K, Friedman J, Heimler I, Aroutcheva A, Simoes J, Fao S. Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case–control study // Infect Dis Obstet Gynecol, 2002; 10:181 – 186]Search in Google Scholar
[7. Belokrinitskaia TE, Vitkovskii IuA, Ponomareva IuN. Role of cytokines in the development of immunologic and homeostatic disorders in advanced dysplasia and carcinoma of the uterine cervix // Vopr Onkol, 2003; 49:51 – 54]Search in Google Scholar
[8. Bermundez-Morales VH, Gutierrez LX, Alcocer-Gonzalez JM, Burguete A, Madrid-Marina V. Correlation between IL-10 gene expression and HPV infection in cervical cancer: a mechanism for immune response escape // Cancer Invest, 2008; 26:1037 – 1043]Search in Google Scholar
[9. Berti FCB, Pereira APL, Cebinelli GCM, Trugilo KP, Brajao de Oliveira K. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma // Cytokine Growth Factor Rev, 2017; 34:1 – 13]Search in Google Scholar
[10. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group // J Natl Cancer Inst, 1995; 87:796-80210.1097/00006254-199510000-00015]Search in Google Scholar
[11. Carrero Y, Mosquera J, Callejas D, Alvarez-Mon M. In situ increased chemokine expression in human cervical intraepithelial neoplasia // Pathol Res Pract, 2015; 211:281 – 285]Search in Google Scholar
[12. Castrilli G, Tatone D, Diodoro MG, Rosini S, Piantelli M, Musiani P. Interleukin 1alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells // Br J Cancer, 1997; 75:855 – 859]Search in Google Scholar
[13. Chua KL, Hjerpe A. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma // Cancer, 1996; 77:121-127]Search in Google Scholar
[14. Ciavattini A, Clemente N, Tsiroglou D, Sopracordevole F, Serri M, Delli Carpini G, Papiccio M, Cattani P. Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be? // Arch Gynecol Obstet, 2017; 295:997 – 1003]Search in Google Scholar
[15. Clerici M, Shearer GM, Clerici E. Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/ TH2 paradigm // J Natl Cancer Inst, 1998; 90: 261 – 263]Search in Google Scholar
[16. Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines // J Allergy Clin Immunol, 2010; 125:S53 – S7210.1016/j.jaci.2009.07.00819932918]Search in Google Scholar
[17. Crowley-Nowick PA, Ellenberg JH, Vermund SH, Douglas SD, Holland CA, Moscicki AB. Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens // J Infect Dis, 2000; 181:939 – 945]Search in Google Scholar
[18. Daniilidis A, Koutsos J, Oikonomou Z, Nasioutziki M, Hatziparadisi K, Tantanasis T. Cytokines of cervical mucosa and human papilloma virus infection of the cervix: A descriptive study // Acta Cytol, 2016; 60:58 – 64]Search in Google Scholar
[19. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 // Int J Cancer, 2015; 136:E359-38610.1002/ijc.2921025220842]Search in Google Scholar
[20. Fernandes AP, Goncalves Ma, Duarte G, Cunha FQ, Simoes RT, Donadi EA. HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels // Virology, 2005; 334:294 – 298]Search in Google Scholar
[21. Fichorova RN, Andreson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells // Biol Reprod. 1999; 60:508 – 514]Search in Google Scholar
[22. Gonzalez-Bosquet E, Fernandez S, Sabra S, Lailla JM. Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer // INT J Gynaecol Obstet, 2017; 136:229 – 231]Search in Google Scholar
[23. Iglesias M, Yen K, Gaiotti D, Hildesheim A, Stoler MH, Woodworth CD. Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha // Oncogene, 1998; 17:1195 – 1205]Search in Google Scholar
[24. Iwata T, Fujii T, Morii T, Saito M, Sugiyama J, Nishio H, Morisada T, Tanaka K, Yaguchi T, Kawakami Y, Aoki D. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia // Int J Clin Oncol, 2015; 20:126 – 133]Search in Google Scholar
[25. Karim R, Meyers C, Backendorf C, Ludigs K, Offringa R, van Ommen GJ, Melief CJ, van der Burg SH, Boer JM. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes // PLoS One, 2011; 6:e1784810.1371/journal.pone.0017848305677021423754]Search in Google Scholar
[26. Kumar V, Abbas A, Aster J. Female genital system and breast // In: Kumar R. Robbins Basic pathology. 9th ed. Philadelphia: Saunders/Elsavier; 2012: 685 – 689]Search in Google Scholar
[27. Liu LB, Xie F, Chang KK, Li MQ, Meng YH, Wang XH, Li H, Li DJ, Yu JJ. Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8 // Int J Clin Exp Pathol, 2014;7:575 – 583]Search in Google Scholar
[28. Long X, Yingnan Y, Zhang L, Liu P, Yu W, Wei F, Ren X, Yu J. IL-8, a novel messenger to cross-link inflammation and tumour EMT via autocrine and paracrine pathways (review) // Int J Oncol, 2015; 48:5 – 12]Search in Google Scholar
[29. Merrick DT, Winberg G, McDougall JK. Reexpression of interleukin 1 in human papillomavirus 18 immortalized keratinocytes inhibits their tumorigenicity in nude mice // Cell Growth Differ, 1996; 7:1661 – 1669]Search in Google Scholar
[30. Mhatre M, McAndrew T, Carpenter C, Burk RD, Einstein MH, Herold BC. Cervical intraepithelial neoplasia is associated with genital tract mucosal inflammation // Sex Transm Dis, 2012; 39: 591 – 597]Search in Google Scholar
[31. Mota F, Rayment N, Chong S. The antigenpresenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium // Clin Exp Immunol, 1999; 116:33 – 40]Search in Google Scholar
[32. Multhoff G, Molls M, Radons J. Chronic inflammation in cancer development // Front Immunol, 2012; 2:98]Search in Google Scholar
[33. Muraille E, Leo O. Revisiting the Th1/Th2 paradigm // Scand J Immunol, 1998; 47:1 – 9]Search in Google Scholar
[34. Paradkar PH, Joshi JV, Mertia PN, Agashe SV, Vaidaya RA. Role of cytokines in genesis, progression and prognosis of cervical cancer // Asian Pac J Cancer Prev, 2014; 15:3851 – 3864]Search in Google Scholar
[35. Peghini BC, Abdalla DR, Barcelos AC, Teodoro Ld, Murta EF, Michelin MA. Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia // Hum Immunol, 2012; 73:920-926]Search in Google Scholar
[36. Pilmane M, Rumba I, Sundler F, Luts A. Patterns of distribution and occurrence of neuroendocrine elements in lungs of humans with chronic lung diseases // Proc. Of Latvian Academy of Sciences, Section B, 1998; 52:144-152]Search in Google Scholar
[37. Rider P, Carmi Y, Voronov E, Apte RN. Interleukin-1α // Semin Immunol, 2013; 25:430-438]Search in Google Scholar
[38. Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease // Int J Clin Lab Res, 1991; 21:152 – 158]Search in Google Scholar
[39. Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Roman JJ, Parham GP, Cannon MJ. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirusspecific CD8(+) cytotoxic T lymphocytes // J Virol, 2000; 74:4729 – 4737]Search in Google Scholar
[40. Scott ME, Ma Y, Kuzmich L, Moscicki AB. Diminished IFN-gamma and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3 // Int J Cancer, 2009; 124:1379 – 1383]Search in Google Scholar
[41. Song SH, Lee JK, Seok OS, Saw HS. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix // Gynecol Oncol, 2007; 104:732 – 738]Search in Google Scholar
[42. Tavares-Murta BM, de Resende AD, Cunha FQ, Murta EF. Local profile of cytokines and nitric oxide in patients with bacterial vaginosis and cervical intraepithelial neoplasia // Eur J Obstet Gynecol Reprod Biol, 2008; 138:93 – 99]Search in Google Scholar
[43. The centre of disease and control of Latvia. Provisional statistical data on citizen mortality // Statistical yearbook of health care in Latvia 2015, 2015; 1:104]Search in Google Scholar
[44. Tjiong MY, van der Vange N, ten Kate FJ, Tjong- A-Hung SP, ter Schegget J, Burger MP, Out TA. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer // Gynecol Oncol, 1999; 73:285 – 291]Search in Google Scholar
[45. Tjiong MY, van der Vange N, ter Schegget JS, Burger MP, ten Kate FW, Out TA. Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia // Cytokine, 2001; 14:357 – 360]Search in Google Scholar
[46. Wei LH, Kuo ML, Chen CA, Cheng WF, Cheng SP, Hsieh FJ, Hsieh CY. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor // Gynecol Oncol, 2001; 82:49 – 56]Search in Google Scholar
[47. Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, Chang MC, Su JL, Hsieh CY. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway // Oncogene, 2001; 20:5799 – 5809]Search in Google Scholar
[48. Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY. Interleukin-6 promotes cervical tumour growth by VEGF-dependent angiogenesis via a STAT3 pathway // Oncogene, 2003; 22:1517 – 1527]Search in Google Scholar
[49. Woodworth CD, McMullin E, Iglesias M, Plowman GD. Interleukin 1 alpha and tumour necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirusimmortalized and carcinoma-derived cervical epithelial cells // Proc Natl Acad Sci U S A, 1995; 92:2840 – 2844]Search in Google Scholar
[50. Woodworth CD, Simpson S. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirusimmortalized, and carcinoma cell lines // Am J Pathol, 1993; 142:1544 – 1555]Search in Google Scholar